Hypoxia and Consequences: From Molecule to Malady
Thursday, March 12, 2009 - Saturday, March 14, 2009
Ask any mountain climber or deep-sea diver: when it comes to oxygen deprivation, timing is everything. The body is not only affected by how long it goes without oxygen, but also by the time it takes for its cells to react to this shortage of oxygen, also known as hypoxia. Both rapid and delayed responses have a profound impact on normal physiological function, and on the progression of diseases such as pulmonary hypertension, sleep apnea, cancer, and neurodegenerative disorders.
Scientific Organizing Committee
- Navdeep S. Chandel, Northwestern University
- Gabriel G. Haddad, University of California, San Diego
- Chris Peers, University of Leeds School of Medicine
The Plenary Sessions have been organized as follows:
Day 1: Transcriptional responses to hypoxia
Day 2: Oxygen sensing
Day 3: Pathophysiological responses to hypoxia
This conference is supported by Award Number R13HL093851 from the National Heart, Lung, and Blood Institute (NHLBI). The content is solely the responsibility of the authors and does not represent the official views of the NHLBI or the NIH.
- BioSpherix, Ltd.
- Bristol-Myers Squibb R&D
- Coy Laboratory Products
- FibroGen, Inc.
- Novus Biologicals, Inc.
- Oncothyreon, Inc.
- R&D Systems, Inc.